Goldenberg Gary 4
4 · Verrica Pharmaceuticals Inc. · Filed Nov 16, 2023
Insider Transaction Report
Form 4
Goldenberg Gary
Chief Medical Officer
Transactions
- Sale
Common Stock
2023-11-14$2.93/sh−5,817$17,044→ 89,293 total - Sale
Common Stock
2023-11-15$2.97/sh−3,036$9,017→ 86,257 total
Footnotes (3)
- [F1]Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on August 24, 2023.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.90 to $3.07 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.95 to $3.00 inclusive.